News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Rahul Banerjee: Multiple Myeloma – Hematologic Toxicities and Advances in Quad Therapies
Rahul Banerjee/X
Dec 5, 2024, 07:37

Rahul Banerjee: Multiple Myeloma – Hematologic Toxicities and Advances in Quad Therapies

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared a post on X:

“ASH24. Looking for mind-blowing facts on Saturday afternoon?  

  • Dara improves OS in ASCT-eligible myeloma.  
  • 42% of MMsm patients have CHIP.  
  • SC boosts fix ICAHT . 
  • Fix Immunoparesis with flu.x3 or IVIG.
  •  sMRD 10^-5 = sMRD 10^-6.

    How much am I oversimplifying? Come find out!”

Read more.

Multiple Myeloma

More posts featuring Rahul Banerjee.

cancer Hematologic Toxicities Immune Toxicities Immunoparesis IVIG Myeloma OncoDaily Oncology patients Quad Therapies Rahul Banerjee University of Washington
Special Coverage
Blog
Dec 5, 2024, 07:37
Rahul Banerjee: Multiple Myeloma - Hematologic Toxicities and Advances in Quad Therapies
Blog
Dec 5, 2024, 07:37
Vivek Subbiah: AI for early cancer detection in Lancet Oncology
Blog
Dec 5, 2024, 07:28
Wafik S. El-Deiry: Dr. Yiqun Zhang’s visit to Brown University
Insight
Dec 5, 2024, 07:25
Carmine Valenza: The Role of Germline BRCA Mutation in PARP Inhibitors-Related Hematologic Adverse Events
Insight
Dec 5, 2024, 00:57
Karen Knudsen: Vaccination against HPV is Cancer Prevention
Blog
Dec 5, 2024, 00:45
Richard Scolyer shared his Cancer Journey at Parliament House in Canberra
Insight
Dec 5, 2024, 00:41
Extreme wrinkling of the nuclear lamina is a morphological marker of cancer
Blog
Dec 5, 2024, 00:30
Akhil Kapoor: Every step forward is a step toward Hope
Blog
Dec 5, 2024, 00:24
Call for Applications for the 2025 SIOP Scientific Programme Advisory Working Group
Insight
Dec 5, 2024, 00:13
Alan Bryce: The manuscript from the 2024 United States Prostate Cancer Consensus Conference
Blog
Dec 5, 2024, 00:09
Manchester Cancer Research Centre’s Director’s Update – November 2024
Insight
Dec 4, 2024, 23:53
Miguel Bronchud: Interesting single-arm, open-label, phase 1 study on CRISPR Therapeutics by Swaminathan Iyer et al.